These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18809585)

  • 1. Bevacizumab in advanced cancer, too much or too little?
    Jirillo A; Vascon F; Giacobbo M
    Ann Oncol; 2008 Oct; 19(10):1817-8. PubMed ID: 18809585
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the real cost of bevacizumab for patients with advanced bowel cancer?
    Dixon L
    Int J Palliat Nurs; 2010 Dec; 16(12):577. PubMed ID: 21240100
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of bevacizumab for the treatment of colorectal cancer.
    Beaumont I
    Int J Palliat Nurs; 2010 Dec; 16(12):576. PubMed ID: 21240099
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab and ranibizumab. Bevacizumab and the inverse postcode lottery.
    Harris MJ
    BMJ; 2010 Jul; 341():c3718. PubMed ID: 20627986
    [No Abstract]   [Full Text] [Related]  

  • 5. Bevacizumab treatment for solid tumors: boon or bust?
    Hayes DF
    JAMA; 2011 Feb; 305(5):506-8. PubMed ID: 21285431
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost comparison of ranibizumab and bevacizumab.
    Jackson TL; Kirkpatrick L
    BMJ; 2011 Aug; 343():d5058. PubMed ID: 21862536
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vision for patients with macular degeneration].
    Paukstadt W
    MMW Fortschr Med; 2007 Jan; 149(3):10-2. PubMed ID: 17619375
    [No Abstract]   [Full Text] [Related]  

  • 8. An ethical view of the ranibizumab and bevacizumab controversy.
    Packer S; Jampol LM
    Arch Ophthalmol; 2008 Feb; 126(2):286; author reply 286-7. PubMed ID: 18268234
    [No Abstract]   [Full Text] [Related]  

  • 9. Nice or not so nice.
    McColgan K
    J Perioper Pract; 2010 Nov; 20(11):386. PubMed ID: 21162353
    [No Abstract]   [Full Text] [Related]  

  • 10. [A new drug for macular degeneration. A breakthrough accomplished (interview by Waldtraud Paukstadt)].
    Holz FG
    MMW Fortschr Med; 2007 Jan; 149(3):13-4. PubMed ID: 17619376
    [No Abstract]   [Full Text] [Related]  

  • 11. Bevacizumab: public opinion might trump science.
    Carlson RH
    Lancet Oncol; 2011 Aug; 12(8):730. PubMed ID: 21928489
    [No Abstract]   [Full Text] [Related]  

  • 12. A poke in the eye.
    Gurney M
    Nurs Older People; 2007 Dec; 19(10):3. PubMed ID: 18220056
    [No Abstract]   [Full Text] [Related]  

  • 13. Price of bevacizumab for intravitreal injection in New Zealand.
    Abeysiri P; Johnston NR; Molteno AC
    Clin Exp Ophthalmol; 2010 Jan; 38(1):84. PubMed ID: 20447111
    [No Abstract]   [Full Text] [Related]  

  • 14. Bevacizumab (Avastin) for metastic breast cancer.
    Med Lett Drugs Ther; 2008 Jun; 50(1287):42-3. PubMed ID: 18509265
    [No Abstract]   [Full Text] [Related]  

  • 15. The cheaper drug, bevacizumab, should be referred to NICE.
    Raftery JP; Lotery A
    BMJ; 2007 Feb; 334(7590):381-2. PubMed ID: 17322218
    [No Abstract]   [Full Text] [Related]  

  • 16. UK needs two-tier National Health Service.
    Lancet Oncol; 2008 Mar; 9(3):185. PubMed ID: 18308237
    [No Abstract]   [Full Text] [Related]  

  • 17. Avastin, ODAC, and the FDA: are we drafting the right players?
    Burstein HJ
    J Natl Compr Canc Netw; 2010 Aug; 8(8):833-4. PubMed ID: 20870630
    [No Abstract]   [Full Text] [Related]  

  • 18. Costs of treatment for age-related macular degeneration.
    Gerson JD
    Optometry; 2009 Jul; 80(7):339. PubMed ID: 19753688
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer drug offers effective, cheaper option for AMD.
    Stephenson J
    JAMA; 2011 May; 305(20):2053-4. PubMed ID: 21610231
    [No Abstract]   [Full Text] [Related]  

  • 20. Study aims to clarify efficacy, safety of eye drug treatments.
    Mitka M
    JAMA; 2007 Apr; 297(14):1538-9. PubMed ID: 17426265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.